COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 2048: Articles 20471-20480  | Next

Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
Zafferani, M., Haddad, C., Luo, L., Davila-Calderon, J., Yuan-Chiu, L., Shema Mugisha, C., Monaghan, A. G., Kennedy, A. A., Yesselman, J. D., Gifford, R. R., Tai, A. W., Kutluay, S. B., Li, M.-L., Brewer, G., Tolbert, B. S., Hargrove, A. E.
10.1101/2020.12.05.409821 — Posted: 2020-12-06 Discussion: Onsite | Offsite
Whole Genome Sequencing for Revealing the Point Mutations of SARS-CoV-2 Genome in Bangladeshi Isolates and their Structural Effects on Viral Proteins
Hossain, M. U., Ahammad, I., Emon, M. T. H., Bhattacharjee, A., Chowdhury, Z. M., Mosaib, M. G., Das, K. C., Keya, C. A., Salimullah, M.
10.1101/2020.12.05.413377 — Posted: 2020-12-06
Machine learning analysis highlights the down-trending of the proportion of COVID-19 patients with a distinct laboratory result profile
Yang, H. S., Hou, Y., Zhang, H., Chadburn, A., Westblade, L. F., Fedeli, R., Steel, P. A., Racine-Brzostek, S. E., Velu, P., Sepulveda, J. L., Satlin, M. J., Cushing, M. M., Kaushal, R., Zhao, Z., Wang, F.
10.1101/2020.11.28.20240150 — Posted: 2020-12-06
The aging whole blood transcriptome reveals a potential role of FASLG in COVID-19
Chuffa, L. G., Souza, J. d. S., de Mello, M. C., Neto, M. d. O., Carvalho, R. F.
10.1101/2020.12.04.412494 — Posted: 2020-12-06
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F., Cashman, K. S., Ramonell, R. P., Kyu, S., Saini, A. S., Cabrera-Mora, M., Derrico, A., Alter, D., Roback, J. D., Horwath, M., O'Keefe, J. B., Wu, H. M., Wong, A.-K. I., Dretler, A. W., Gripaldo, R., Lane, A. N., Wu, H., Lee, S., Hernandez, M., Engineer, V., Varghese, J., Le, S., Sanz, I., Daiss, J. L., Lee, F. E.-H.
10.1101/2020.12.04.410589 — Posted: 2020-12-06
Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro
Ohgitani, E., Shin-Ya, M., Ichitani, M., Kobayashi, M., Takihara, T., Kawamoto, M., Kinugasa, H., Mazda, O.
10.1101/2020.12.04.412098 — Posted: 2020-12-06
Online biophysical predictions for SARS-CoV-2 proteins
Kagami, L., Martinez, J. R., Garcia, J. G., Ramasamy, P., Feenstra, K. A. A., Vranken, W. F.
10.1101/2020.12.04.411744 — Posted: 2020-12-05
Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity
Giroux, N. S., Ding, S., McClain, M. T., Burke, T. W., Petzold, E. W., Chung, H. A., Palomino, G. R., Wang, E., Xi, R., Bose, S., Rotstein, T., Nicholson, B. P., Chen, T., Henao, R., Sempowski, G. D., Denny, T. N., Ko, E. R., Ginsburg, G. S., Kraft, B. D., Tsalik, E. L., Woods, C. W., Shen, X.
10.1101/2020.12.04.412155 — Posted: 2020-12-05
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro
Unal, M. A., Bitirim, C. V., Summak, G. Y., Bereketoglu, S., Cevher Zeytin, I., Besbinar, O., Gurcan, C., Aydos, D., Goksoy, E., Kocakaya, E., Eran, Z., Murat, M., Demir, N., Somers, J., Demir, E., Nazir, H., Ozkan, S. A., Ozkul, A., Azap, A., Yilmazer, A., Akcali, K. C.
10.1101/2020.12.04.410092 — Posted: 2020-12-05
Quality of life and depressive symptoms among Peruvian university students during the COVID-19 pandemic
Figueroa-Quinones, J., Ipanaque-Zapata, M., Machay-Pak, D., Rodriguez-Ruiz, J.
10.1101/2020.12.04.411330 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).